Pages that link to "Item:Q3429959"
From MaRDI portal
The following pages link to Power, sample size and adaptation considerations in the design of group sequential clinical trials (Q3429959):
Displaying 14 items.
- Modern sequential analysis and its applications to computerized adaptive testing (Q477962) (← links)
- Most powerful test sequences with early stopping options (Q2124787) (← links)
- Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes (Q2308435) (← links)
- Asymptotically optimal multistage tests of simple hypotheses (Q2466684) (← links)
- Active postmarketing drug surveillance for multiple adverse events (Q2797469) (← links)
- Generalized Sequential Probability Ratio Test for Separate Families of Hypotheses (Q2934414) (← links)
- Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials (Q3527716) (← links)
- Efficient Adaptive Randomization and Stopping Rules in Multi-arm Clinical Trials for Testing a New Treatment (Q4650223) (← links)
- Complementary hypotheses in safety surveillance (Q4965656) (← links)
- Bandit Theory: Applications to Learning Healthcare Systems and Clinical Trials (Q5072150) (← links)
- Asymptotically Optimal Sequential Design for Rank Aggregation (Q5868958) (← links)
- Beyond boundaries: Gary Lorden’s groundbreaking contributions to sequential analysis (Q6620752) (← links)
- Asymptotically optimal multistage tests for non-i.i.d. data (Q6621338) (← links)
- Adaptive enrichment designs for confirmatory trials (Q6625662) (← links)
